VOQUEZNA (vonoprazan) — Topline data
Q4 2026
Topline results from the 12-week blinded treatment portion of the trial are expected during the fourth quarter of 2026.Source filing
PHAT biotech catalysts & pipeline
PHATHOM PHARMACEUTICALS INC · Data as of 2026-09-08